Cirqle Biomedical Secures Pre-Seed Funding for Next Generation Contraceptive - Business Wire

Cirqle Biomedical Secures Pre-Seed Funding for Next Generation Contraceptive  Business Wire

Cirqle Biomedical today announced that it has secured $1.8M for pre-clinical development of a novel non-hormonal contraceptive technology.



Comments

Popular Posts

Community-Acquired Pneumonia: Symptoms and Treatment - Verywell Health

How to Decode Your Baby's Cough - Yahoo Lifestyle